375
Views
7
CrossRef citations to date
0
Altmetric
Drug Evaluation

Pharmacokinetic drug evaluation of ulipristal acetate for the treatment of uterine fibroids

ORCID Icon, ORCID Icon & ORCID Icon
Pages 107-116 | Received 29 Sep 2017, Accepted 11 Dec 2017, Published online: 20 Dec 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (7)

Giulio Evangelisti, Fabio Barra, Umberto Perrone, Nadine Di Donato, Stefano Bogliolo, Marcello Ceccaroni & Simone Ferrero. (2022) Comparing the pharmacokinetic and pharmacodynamic qualities of current and future therapies for uterine fibroids. Expert Opinion on Drug Metabolism & Toxicology 18:7-8, pages 441-457.
Read now
Fabio Barra, Giulio Evangelisti & Simone Ferrero. (2021) Preoperative Hormonal Treatment Before Laparoscopic Approach for Uterine Fibroids: Do We Need It?. Journal of Investigative Surgery 34:4, pages 451-453.
Read now
Simona Del Forno, Eugenia Degli Esposti, Paolo Salucci, Deborah Leonardi, Raffaella Iodice, Alessandro Arena, Diego Raimondo, Roberto Paradisi & Renato Seracchioli. (2020) Liver function, tolerability and satisfaction during treatment with ulipristal acetate in women with fibroids: a single center experience. Gynecological Endocrinology 36:5, pages 445-447.
Read now
Mohamed Ali & Ayman Al-Hendy. (2018) Uterine fibroid therapy: the pharmacokinetic considerations. Expert Opinion on Drug Metabolism & Toxicology 14:9, pages 887-889.
Read now
Simone Ferrero, Giulio Evangelisti & Fabio Barra. (2018) Current and emerging treatment options for endometriosis. Expert Opinion on Pharmacotherapy 19:10, pages 1109-1125.
Read now
Fabio Barra, Carolina Scala, Valerio Mais, Stefano Guerriero & Simone Ferrero. (2018) Investigational drugs for the treatment of endometriosis, an update on recent developments. Expert Opinion on Investigational Drugs 27:5, pages 445-458.
Read now

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.